These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 12480917)
1. Rapid trafficking of membrane type 1-matrix metalloproteinase to the cell surface regulates progelatinase a activation. Zucker S; Hymowitz M; Conner CE; DiYanni EA; Cao J Lab Invest; 2002 Dec; 82(12):1673-84. PubMed ID: 12480917 [TBL] [Abstract][Full Text] [Related]
2. TIMP-2 is released as an intact molecule following binding to MT1-MMP on the cell surface. Zucker S; Hymowitz M; Conner C; DeClerck Y; Cao J Exp Cell Res; 2004 Feb; 293(1):164-74. PubMed ID: 14729066 [TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Lehti K; Lohi J; Valtanen H; Keski-Oja J Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492 [TBL] [Abstract][Full Text] [Related]
4. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743 [TBL] [Abstract][Full Text] [Related]
5. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Bernardo MM; Fridman R Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684 [TBL] [Abstract][Full Text] [Related]
6. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
7. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911 [TBL] [Abstract][Full Text] [Related]
8. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. Butler GS; Butler MJ; Atkinson SJ; Will H; Tamura T; Schade van Westrum S; Crabbe T; Clements J; d'Ortho MP; Murphy G J Biol Chem; 1998 Jan; 273(2):871-80. PubMed ID: 9422744 [TBL] [Abstract][Full Text] [Related]
9. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650 [TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). Zucker S; Drews M; Conner C; Foda HD; DeClerck YA; Langley KE; Bahou WF; Docherty AJ; Cao J J Biol Chem; 1998 Jan; 273(2):1216-22. PubMed ID: 9422789 [TBL] [Abstract][Full Text] [Related]
11. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation. Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943 [TBL] [Abstract][Full Text] [Related]
12. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942 [TBL] [Abstract][Full Text] [Related]
13. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
14. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
15. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. Will H; Atkinson SJ; Butler GS; Smith B; Murphy G J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332 [TBL] [Abstract][Full Text] [Related]
16. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341 [TBL] [Abstract][Full Text] [Related]
17. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells. Luo XH; Liao EY Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673 [TBL] [Abstract][Full Text] [Related]
18. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Foda HD; George S; Conner C; Drews M; Tompkins DC; Zucker S Lab Invest; 1996 Feb; 74(2):538-45. PubMed ID: 8780171 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596 [TBL] [Abstract][Full Text] [Related]
20. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. Hernandez-Barrantes S; Toth M; Bernardo MM; Yurkova M; Gervasi DC; Raz Y; Sang QA; Fridman R J Biol Chem; 2000 Apr; 275(16):12080-9. PubMed ID: 10766841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]